Form 4 for PRVA Privia Health Group, Inc.

Accepted 2026-05-13 19:40:30 ET · period of report 2026-05-11 · accession 0001759655-26-000030 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MT	2026-05-13 19:40	2026-05-11+	PRVA	Mehrotra Parth	CEO, Dir	S - Sale	$22.56	-121.1K	434.4K	-22%	-$2.73M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, $0.01 par value per share	2026-05-11	S	D	105,439	$22.55	450,004	D	—	—	(F1) Certain of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and certain of the sales represent a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.28 to $23.10 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
2	Common	Common Stock, $0.01 par value per share	2026-05-12	S	D	15,647	$22.64	434,357	D	—	—	(F3) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person